10-·|Ä³°O¿ý-37-81

Size: px

Start display at page:

Download "10-·|Ä³°O¿ý-37-81"

缎党
7 years ago
Views:

1 /28-9/1 ESC 37

2 ESC affiliated member ESC Joint Symposium affiliated member under china president affiliated member arrhythmia EP pocket guideline paper references update update APCC open international session presentation fellow

pocket guideline paper references update update 99 12 18-19

3 ( ) ( ) Post-ESC overview ( )

4 (1) (2) 500 (3) 200 (1) 50 (2) (3) 75 (1) (2) 100 (1) (2) 500 (3) 50 1) (1) 50 2) 3. 1)

5 2) ) 2) F1+F2 3) ( ) PubMed Review articles 5. Ovid or Elsevier 6. ( ) 1. 5 Plenary Session, Symposia, Policy Debates, Guideline Promotion, Oral Session, Poster Session, YIA Competition, Live Demonstration, Ethics Topic 12 Plenary Session, Symposia, Guideline Promotion, Debates, Ethics Topic 41

6 Guidelines etc GCP GCP (1) Plenary speaker Heart Failure: Karl Swedberg, MD, PhD, FESC, FACC, FAHA Servier 2. PCI: Louvard Yves 3. Biomaker: Prof. Alan S. Maisel topic update commercial 4. Stem cell: Prof. Hung-Fat Tse, HK (2) Plenary Speech or Keynote Speech Plenary Speech 4 (3) 2011 Central Theme New Frontiers (4) (5) International Young Investigator Presentation Session 1~2 Young Investigator commentator 5/15 W

Maisel topic update commercial 4. Stem cell: Prof. Hung-Fat Tse, HK (2) 99.11.

7 Presentation 20 mins; Q&A: 5~10 mins JCS 11 (6) Young Investigator Award Competition: well-known Young investigator (7) Oral presentation (8) Chair Speaker (9) on time chair ( ) AHA 1) _Oral session Heart Failure Enhanced Fibrillatory Activity in Small Pulmonary Vein and Left Atrium Tissue: Potential Mechanisms of Atrial Fibrillation 2) _Oral session Neurocognitive Improvement after Carotid Artery Stenting Is Persistent Up to 1 Year in Patients with Chronic Occlusion or Critical Stenosis 3) _Poster session Plasma Levels of TNF- and II-6 are Associated with Diastolic Heart Failure Through Downregulation of Sarcoplasmic Reticulum Ca 2+ Atpase 1. AHA NT.60,000.- NT.180, NT. 120,000 43

Neurocognitive Improvement after Carotid Artery Stenting Is Persistent Up to 1 Year in Patients with Chronic Occlusion or Critical Stenosis 3) _Poster session Plasma Levels of

8 (1) AHA ACC ESC abstract oral poster (2) oral presentation 1 poster 0.5 abstract (3) abstract (4) 3. Multi-center (Reigistry of AntiPlatelet Agents and Platelet Residual Function EvaluatiOn after PeRcutaneous Intervention of CoronaAry STEnts: A Multi-centers Study in Taiwan (APPROPRIATE study) 1) 2) 4. 1) 5/14_w6 DNA 2)

Multi-center (Reigistry of AntiPlatelet Agents and Platelet Residual Function

9 5. basic research ) Basic Research 2) Central Theme New Frontiers Plenary Speech or Keynote Speech Plenary Speech Basic Research ( ) Registry PCI, AMI, Pacemaker implantation, Cardiac-resynchronization, ICD Implantation, D2B

30 Plenary Speech or Keynote Speech Plenary Speech 4 2011 Basic Research (

10 (1) - - (2) IVUS (3) PTA (4) cutting balloon (5) DRG 3. ( ) References Overview 3. pdf 2. section (1)

11 (2) (3) 2. (1) (2) (3) (4) (5) (6) 4. ( ) ) ) 10 3) 4 (1)

12 (2) S NO 11 NO NO S NO NO 2. 1) 2) 100 1) 2) )

13 2) DRG Q1~Q3 DRG 1. type B dissection 2. CABG + Valve CABG + other procedure 3. Complex Heart Disease 4. double valve replacement 3) Hybrid Symposium or Workshop Foundamental concept & skill 1) 2011 CHD VHD 2) Dr.Song ( Plenary Speech Satellite Symposium 3) section 180 (1) CHD- VSD TF (2) Valve- Aortic valve Mitral valve Tricuspid valve 4) 2012 Aortic disease Coronary artery disease 5) 2012 Section 49

14-15 2012 101 5 5-6 2011-12 Foundamental concept & skill 1) 2011 CHD VHD 2) Dr.

14 ( ) 1. 1) 2) 3) 1. RVRBS Cath 2.5 Cath 1.5 Cath 1/4 3 -> Pulmonary Artery Balloon Dilatation PTCA Workshop Post Congress Highlight Workshop Post Congress Highlight ) ~15 Keynote Speech 2) Workshop (1). Percutaneuous Pulmonary valve Replacement (2). ACHD Preventive Medicine Free Paper

-> Pulmonary Artery Balloon Dilatation PTCA 2. 3.

15 3. (1) BT Shunt CABG 1/4 (2) TCPC TCPC 4. DRG DRG Asian-Pacific Symposium of Hypertension 2011 Asian-Pacific Symposium of Hypertension 2 Dr.McCrindle Dr.Niwa Dr. ( ) 1. 1) 2) AHA, ACC, ESC,IAS,ISH 3) Post-AHA, Post-ACC, Post-ESC Symposia, 4) 5) A. (1) AHA ACC ESC abstract oral poster (2) oral presentation 1 poster 0.5 abstract (3) abstract First Author (4) 51

16 B. (1) abstract (2) field (3) (4) post-aha post-acc post-esc symposia (5) (6) a) intervention b) c) ( ) Registry Study

17 (1) 100 1) 2) NT$1,000,000.- NT$ 1,500, ) 99 4) 99 NT$200,000.- NT$1,000,000.- NT$85,000.- NT$700, ) 6) 7) (2) 99 1) 1-8 2) 1-8 $770, ) 1-8 $1,780,060.- $800,

18 () guidelines, case discussion, new drugs new strategies live demonstration live demonstration 4. AMI 2. Post EuroPCR and ESC Highlight Symposium 1) 2) 3. () AF, VT, AFL, PSVT- simple & complex

19 2. pacemaker device ICD pacemaker ICD pacemaker 2 - CRT-D, CRT-P pacemaker 3 3. CRT-D, CRT-P EP 2. DRG in ICD and CRT ICD ICD DRG 1) ICD, ICD+CRT, CRT-P, CRT_D 2) 3) device follow-up 3. 1) Joint Education 2) EP working group AF awareness Syncope3 3) EP working group local 55

20 4. () 1. ACLS Renewal Course 4 ACLS SCCM Update Course 2. _2010.1~ ) 2) 3) 4) AMI Heart Failure ACS ) 12/19(W6)13:30~17:

21 2) 3) A 4 () workshop workshop stress echocardiography 3D echocardiography ) 2) () Taiwan Hypertension Guidelines 1 handout 2 Taiwan Hypertension Guidelines PDF 10 JFMA publish 57

22 Hypertension Guidelines and Beyond full disclosure 2012 Taiwan Hypertension Guidelines 1 Class I II III Level of Evidence 2 3 guidelines conflict of interest 4 guidelines guidelines 2011 APCH Guidelines 11 1 Hypertension Guidelines and Beyond full disclosure HT Guideline and Beyond HT Guideline and Beyond

23 Time Topic 14:00-14:10 Opening remarks 14:10-14:30 Life style: really important, but rarely performed 14:30-14:50 Diuretics: use or not use? 14:50-15:10 How low is too low? 15:10-15:30 Healthy break 15:30-15:50 Direct renin inhibitor: final solution? 15:50-16: Pharmacological treatment of HT 16:20-16:50 Panel discussion 16:50-17:00 Closing remarks Guideline 10~12 () ESC APSC 3. guideline - ACC/AHA/ESC guideline 2010 Heart Failure Society of North American - HF guideline review

24 APSC-ESC_HF Registry ESC Heart Failure Registry Investigators Meeting () qualified Chest x-ray General Cardiology PCI Echo EPS history/pe 2. Fellow 3. & topics (w7) 08:30-12:00am Q&A

25 1) 2) copayment 3) 4) ( ) 1) 2) 3) 4) ( ) 61

27 63

28 ( ) ( ) ( ) ( )

29 65

30 ( ) ( ) ( ) (S1380)

31 7 _ 99 ( )

32 ( ) (1)

33 ) ) ) )

34 5) ) 100 (2) No. 1 2 /

35 (3) No

36 (4) (5) 1. Original Case Report fellow

37 ( ) (1) Relationship between Ambulatory Blood Pressure Variability, Dayby-day Home Blood Pressure Variability and Arterial Stiffness in Untreated Essential Hypertension / Proteome of hydrogen sulfide in endothelial cell / 2. NT.289, (2)

38 (1) (2) (3) ( ) / / ACC/AHA/ESC paper 2. Oral Poster] / / ACC/AHA/ESC paper 2. Oral Poster

39 _ ACC/AHA/ESC presenter presenter _ ACC/AHA/ESC ACC AHA 10 ESC15-20 AHA AHA ACC/ESC fellow sponsor 75

40 present ( ) _ NT$15,000.-/ NT.$15,000.-/ NT. 15,000.-/ 8 = NT.12,000.- / NT$15,000.-/ NT.$15,000.-/ NT.15,000.-/ 8 = NT.12,000.-/

41 ( ) registration form (1) _ (1)(2) 40% (3)(4) 77

42 (2) _ (3) _ ICU

43 () (4) APCC ESC-APSC congress2011 APCC APSC fellowship (5) 79

44 第廿二屆第三次理監事聯席會議會議紀錄附件一年 11 月號

45 81

08-·|Ä³°O¿ý-19-48

08-·|Ä³°O¿ý-19-48 11 13 1 World Hear Federation "T" "C" China ACC Taiwan China ACC region member chapter final 19 98 4 ESC affliated member ESC free World Heart Congress Scientific program committee member hot topic session